Professor Huntington is the founder and CSO of oNKo-Innate Pty Ltd, a Melbourne-based Immuno-oncology Biotech. He is an international opinion leader on natural killer (NK) cell biology and NK cell immunotherapy with notably contributions to: regulatory mechanisms of IL-15 signalling, identification of human and murine NK cell differentiation pathways and identification of multiple checkpoint in NK cell activation and tumour immunity. Professor Huntington has published over 130 research articles on NK cell biology and cancer immunotherapy and has been recognised internationally with fellowships from HFSP, Melanoma Research Alliance, Cancer Research Institute and NHMRC and was the winner of the AAS Jacques Miller Award and NFMRI John Dixson Hughes Medal. Professor Huntington heads the Cancer Immunotherapy laboratory at Monash University Biomedicine Discovery Institute.